copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Johnson Johnson: Changing health for humanity Johnson Johnson Innovative Medicine is leading where medicine is going Patients inform and inspire our science-based innovations, which continue to change and save lives With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the medicines of tomorrow
Johnson Johnson - Wikipedia Johnson Johnson (J J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No 42 on the 2024 Fortune 500 list of the largest United States corporations [2
About Us - J J MedTech Learn about Our Credo, Leadership team, Policies and Statements, Code of Business Conduct and Company Structure Take a closer look at Johnson Johnson MedTech Learn about career opportunities, commitments values, and our different companies products
Our company - Johnson Johnson At Johnson Johnson, we believe health is everything Every day, our more than 138,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal For 139 years, we have aimed to keep people well at every age and every stage of life
We are here to transform the future of health Headquartered in Titusville, New Jersey, Janssen is named after Dr Paul Janssen, a leading pharmaceutical researcher, pharmacologist and general practitioner His company, Janssen Pharmaceutica, joined the Johnson Johnson family of companies in 1961
Johnson Johnson Reports Q1 2025 Results - investor. jnj. com NEW BRUNSWICK, N J -- (BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for first-quarter 2025 “The power of Johnson Johnson’s uniquely diversified portfolio was on full display this quarter, with strong operational sales growth reinforcing our confidence in 2025 guidance,” said Joaquin Duato, Chairman and Chief